Dog Dewormers Market – By Product Type, Distribution Channel - Global Forecast, 2024 – 2032

Dog Dewormers Market Size

The global dog dewormers market size was valued at around USD 1.4 billion in 2023 and is estimated to grow at a 9.5% CAGR from 2024 to 2032. Increased pet ownership and a rising focus on zoonotic diseases are driving the growth of the market.
 

The growing trend of pet ownership is a key driver behind the expansion of the market. Factors contributing to this increase in pet ownership include changing lifestyles and urbanization, where more people seek companionship through pets, especially dogs. Additionally, the American Pet Products Association (APPA) reported that 66% of U.S. households owned pets in 2023, while global spending on veterinary care and products reached USD 35.9 billion in 2022. This combination of factors continues to fuel the growth of the market as pet owners prioritize preventive care to ensure their pets remain healthy.
 

Furthermore, the rising focus on zoonotic diseases, which are transmitted from animals to humans, is driving the growth of the dog dewormers market as awareness increases about the risks posed by parasitic infections in pets. Worms such as roundworms and hookworms can spread from dogs to humans, leading to serious health concerns. As a result, pet owners and veterinarians are placing greater emphasis on regular deworming to prevent the transmission of these diseases, further boosting the demand for dog dewormers.
 

Dog dewormers are veterinary medications specifically formulated to eliminate or prevent parasitic worm infestations in dogs, such as roundworms, hookworms, tapeworms, and whipworms. These treatments help protect dogs from the health issues caused by these parasites and reduce the risk of zoonotic disease transmission to humans.
 

Dog Dewormers Market Trends

The latest technological advancements in dog dewormers are playing a crucial role in driving the growth of the market. These innovations enhance efficacy, convenience, and safety, encouraging more pet owners to adopt regular deworming practices for their dogs.
 

• Newer dewormers offer extended-release formulations that provide long-lasting protection, reducing the need for frequent dosing. For instance, injectable dewormers such as ProHeart 12 (Zoetis) offer protection against heartworms and intestinal parasites for up to 12 months with a single dose, improving compliance and convenience for pet owners.
   
• Additionally, advances in combination therapies allow a single treatment to target multiple types of parasites. Products like Interceptor Plus (Elanco Animal Health) and NexGard Spectra (Boehringer Ingelheim Animal Health) protect against a broad spectrum of internal and external parasites, offering all-in-one protection with fewer medications, which simplifies parasite control for pet owners.
   
• Moreover, modern injectable and topical dewormers feature improved delivery systems that enhance absorption and reduce side effects. These technologies ensure precise dosages and make administration easier, particularly for pets that struggle with oral medications. These technological advancements make dog deworming more effective, convenient, and safe, contributing to the growing demand and expansion of the market.
   

Dog Dewormers Market Analysis

Based on product type, the dog dewormers market is classified into tablets and chewable treats, topical solutions, and injections. The tablets and chewable treats segment generated the highest revenue of USD 768.6 million in 2023.
 

• Tablets and chewable treats dominate the market due to their convenience, ease of administration, and high compliance rates among pet owners. These formulations are typically easier to give to dogs, as chewables are often flavored to be more palatable, making them more likely to be consumed without resistance.
   
• Additionally, tablets and chewable treats offer precise dosing and are widely available over the counter, making them accessible to a broader range of pet owners. Their affordability compared to other forms, such as injections or topical solutions, also contributes to their dominance in the market. These factors collectively drive their popularity, leading to their heightened market share.
   

Based on the distribution channel, the dog dewormers market is classified into veterinary clinics, retail pharmacies, online platforms, and pet stores. The veterinary clinics segment generated the highest revenue of USD 560.2 million in 2023.
 

• Veterinarians provide professional diagnosis and personalized treatment plans, ensuring that the dewormers prescribed are specifically suited to the dog’s condition. This expert guidance increases pet owners' confidence in the effectiveness and safety of the dewormers they purchase.
   
• Additionally, many effective dewormers, especially those requiring higher potency or specific formulations, are available only through veterinary clinics. This access to prescription-strength medications, which are not always available through retail pharmacies or online platforms, makes veterinary clinics a primary source for purchasing dewormers.
   

North America's dog dewormers market accounted for USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% between the 2024 and 2032.
 

• North America, particularly the U.S. and Canada, has one of the highest rates of pet ownership in the world. The increasing number of households with pets drives the demand for dog dewormers, as owners seek to ensure their pets are free from parasites.
   
• Additionally, there is a heightened awareness of the importance of preventive animal healthcare for pets in North America. Pet owners are more informed about the risks of parasitic infections and are therefore more likely to invest in regular deworming treatments.
   

The U.S. held a dominant position in the dog dewormers market, with revenue of USD 473.5 million in 2023.
 

• The U.S. sees significant spending on veterinary care, with pet owners increasingly prioritizing their pets' health. This includes spending on preventive treatments like dewormers to maintain overall pet health.
   
• Additionally, the U.S. market benefits from continuous innovation in pet health products, including dewormers. New formulations and delivery methods, such as extended-release and combination products, drive growth by offering more effective and convenient solutions.
   

The UK dog dewormers market is anticipated to witness substantial growth from 2024 to 2032.
 

• In the UK, strong regulatory frameworks and pet health campaigns promote regular deworming and parasite control. This regulatory support encourages pet owners to follow recommended deworming schedules.
   
• Moreover, the UK’s rigorous veterinary care standards, including preventive health measures, drive the adoption of effective deworming treatments. Pet owners are more likely to follow through with recommended deworming regimens to meet these high standards.
   

Japan holds a dominant position in the Asia Pacific dog dewormers market.
 

• In Japan, innovative pet wellness programs and clinics that offer comprehensive health solutions, including advanced deworming treatments, are increasingly popular. These programs contribute to the growth of the market by providing specialized care.
   
• Japanese pet owners place a strong cultural emphasis on ensuring the longevity and well-being of their pets. This cultural focus drives investment in preventive healthcare measures like deworming, aiming to improve and extend their pets’ lives.
   

Dog Dewormers Market Share

The market is characterized by its fragmented nature, with a diverse mix of large multinational corporations, and small and mid-sized companies all vying for market share. Key strategies for companies in this sector include the development and introduction of innovative deworming treatments that offer enhanced efficiency and cost-effectiveness. This focus on innovation drives competition and advances in the market, as companies seek to address evolving clinical needs and improve pet health outcomes. By leveraging novel formulations and delivery methods, businesses aim to capture a larger market share and meet the rising demand for advanced dog deworming solutions.
 

Dog Dewormers Market Companies

Some of the eminent market participants operating in the Dog Dewormers industry include:

• Bayer AG
• Beaphar
• Bimeda, Inc.
• Boehringer Ingelheim International GmbH
• Ceva Santé Animale
• Durvet Animal Health Products
• Elanco Animal Health Incorporated 
• Jurox Pty Limited
• Merck & Co., Inc.
• Ourofino Animal Health
• PetIQ, LLC.
• Sava Healthcare Limited
• Vetoquinol
• Virbac SA
• Zoetis Inc.
   

Dog Dewormers Industry News:

• In April 2024, Boehringer Ingelheim announced the launch of NexGard SPECTRA in India, following its approval by the Central Drugs Standard Control Organization (CDSCO). This represents an expansion of the NexGard product line and is expected to generate revenue for the company.
   

Dog dewormers market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Tablets and chewable treats
• Topical solutions
• Injections                          

By Distribution Channel

• Veterinary clinics
• Retail pharmacies
• Online platforms
• Pet stores

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa